<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">IJO</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26655012</article-id><article-id pub-id-type="pmc">4728986</article-id><article-id pub-id-type="publisher-id">IJO-63-804b</article-id><article-id pub-id-type="doi">10.4103/0301-4738.171528</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letters to the Editor</subject></subj-group></article-categories><title-group><article-title>Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema: A prospective, randomized comparative study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kucukevcilioglu</surname><given-names>Murat</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Koylu</surname><given-names>Mehmet Talay</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Ayyildiz</surname><given-names>Onder</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ozge</surname><given-names>Gokhan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Ophthalmology, Gulhane Military Medical School, Ankara, Turkey</aff><aff id="aff2"><label>1</label>Department of Ophthalmology, Tatvan Military Hospital, Bitlis, Turkey</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Dr. Murat Kucukevcilioglu, Department of Ophthalmology, Gulhane Military Medical School, Ankara, Turkey. E-mail: <email xlink:href="eyedrmuratk@gmail.com">eyedrmuratk@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2015</year></pub-date><volume>63</volume><issue>10</issue><fpage seq="b">804</fpage><lpage>805</lpage><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Dear Sir,</p><p>We read with interest the paper &#x0201c;Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema (DME). A prospective, randomized comparative study&#x0201d; written by Raizada <italic>et al</italic>.[<xref rid="ref1" ref-type="bibr">1</xref>] They found that both 3 monthly injection of bevacizumab and vitrectomy with internal limiting membrane (ILM) peeling is equally effective in vision gain and macular thickness reduction. They did not observe any serious adverse effects in both study arms. Interestingly, they showed that macular thickness reduction is more profound in the vitrectomy group with an earlier maximum visual gain than bevacizumab group. They mentioned that ILM peeling may cause further photoreceptor damage which we think needs further elaboration. Recently, Ripandelli <italic>et al</italic>. evaluated the functional outcomes of ILM peeling in patients with idiopathic epiretinal membrane in a comparative study and showed that mean retinal sensitivities on microperimetry in 4&#x000b0; and 12&#x000b0; central subfields were significantly lower in ILM peeled group.[<xref rid="ref2" ref-type="bibr">2</xref>] Moreover, they demonstrated significantly higher number of absolute microscotomas in 12&#x000b0; central subfield during the 12-month follow-up. Romano <italic>et al</italic>. reported that ILM peeling may cause further damage to M&#x000fc;ller cells, and collapse of intraretinal scaffold which can be seen as submacular atrophy in nontractional DME) cases.[<xref rid="ref3" ref-type="bibr">3</xref>] Yoshikawa <italic>et al</italic>. investigated topographical changes after ILM peeling in DME patients and showed macular displacement toward the optic disc.[<xref rid="ref4" ref-type="bibr">4</xref>] This may have some functional implications such as impaired fixation characteristics or stereopsis. All these observations prove that not only distance visual acuity but also other components of the visual function need to be considered.</p><sec disp-level="2" id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec disp-level="2" id="sec2-2"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raizada</surname><given-names>S</given-names></name><name><surname>Al Kandari</surname><given-names>J</given-names></name><name><surname>Al Diab</surname><given-names>F</given-names></name><name><surname>Al Sabah</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Mathew</surname><given-names>S</given-names></name></person-group><article-title>Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study</article-title><source>Indian J Ophthalmol</source><year>2015</year><volume>63</volume><fpage>504</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">26265641</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripandelli</surname><given-names>G</given-names></name><name><surname>Scarinci</surname><given-names>F</given-names></name><name><surname>Piaggi</surname><given-names>P</given-names></name><name><surname>Guidi</surname><given-names>G</given-names></name><name><surname>Pileri</surname><given-names>M</given-names></name><name><surname>Cupo</surname><given-names>G</given-names></name><etal/></person-group><article-title>Macular pucker: To peel or not to peel the internal limiting membrane? A microperimetric response</article-title><source>Retina</source><year>2015</year><volume>35</volume><fpage>498</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">25158943</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>MR</given-names></name><name><surname>Romano</surname><given-names>V</given-names></name><name><surname>Vallejo-Garcia</surname><given-names>JL</given-names></name><name><surname>Vinciguerra</surname><given-names>R</given-names></name><name><surname>Romano</surname><given-names>M</given-names></name><name><surname>Cereda</surname><given-names>M</given-names></name><etal/></person-group><article-title>Macular hypotrophy after internal limiting membrane removal for diabetic macular edema</article-title><source>Retina</source><year>2014</year><volume>34</volume><fpage>1182</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">24846134</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Nishijima</surname><given-names>K</given-names></name><name><surname>Uji</surname><given-names>A</given-names></name><name><surname>Ogino</surname><given-names>K</given-names></name><name><surname>Horii</surname><given-names>T</given-names></name><etal/></person-group><article-title>Macular migration toward the optic disc after inner limiting membrane peeling for diabetic macular edema</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><fpage>629</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">23299482</pub-id></element-citation></ref></ref-list></back></article>